Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.
Chirogate is a professional Prostaglandin manufacturer.
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
Century has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Parenteral
Topical
Film Formers & Plasticizers
Emulsifying Agents
Thickeners and Stabilizers
Surfactant & Foaming Agents
Controlled & Modified Release
Direct Compression
Co-Processed Excipients
Rheology Modifiers
Coating Systems & Additives
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Latanoprostene Bunod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Latanoprostene Bunod, including repackagers and relabelers. The FDA regulates Latanoprostene Bunod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Latanoprostene Bunod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Latanoprostene Bunod manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Latanoprostene Bunod supplier is an individual or a company that provides Latanoprostene Bunod active pharmaceutical ingredient (API) or Latanoprostene Bunod finished formulations upon request. The Latanoprostene Bunod suppliers may include Latanoprostene Bunod API manufacturers, exporters, distributors and traders.
click here to find a list of Latanoprostene Bunod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Latanoprostene Bunod DMF (Drug Master File) is a document detailing the whole manufacturing process of Latanoprostene Bunod active pharmaceutical ingredient (API) in detail. Different forms of Latanoprostene Bunod DMFs exist exist since differing nations have different regulations, such as Latanoprostene Bunod USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Latanoprostene Bunod DMF submitted to regulatory agencies in the US is known as a USDMF. Latanoprostene Bunod USDMF includes data on Latanoprostene Bunod's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Latanoprostene Bunod USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Latanoprostene Bunod suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Latanoprostene Bunod Drug Master File in Korea (Latanoprostene Bunod KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Latanoprostene Bunod. The MFDS reviews the Latanoprostene Bunod KDMF as part of the drug registration process and uses the information provided in the Latanoprostene Bunod KDMF to evaluate the safety and efficacy of the drug.
After submitting a Latanoprostene Bunod KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Latanoprostene Bunod API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Latanoprostene Bunod suppliers with KDMF on PharmaCompass.
A Latanoprostene Bunod written confirmation (Latanoprostene Bunod WC) is an official document issued by a regulatory agency to a Latanoprostene Bunod manufacturer, verifying that the manufacturing facility of a Latanoprostene Bunod active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Latanoprostene Bunod APIs or Latanoprostene Bunod finished pharmaceutical products to another nation, regulatory agencies frequently require a Latanoprostene Bunod WC (written confirmation) as part of the regulatory process.
click here to find a list of Latanoprostene Bunod suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Latanoprostene Bunod as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Latanoprostene Bunod API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Latanoprostene Bunod as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Latanoprostene Bunod and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Latanoprostene Bunod NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Latanoprostene Bunod suppliers with NDC on PharmaCompass.
Latanoprostene Bunod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Latanoprostene Bunod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Latanoprostene Bunod GMP manufacturer or Latanoprostene Bunod GMP API supplier for your needs.
A Latanoprostene Bunod CoA (Certificate of Analysis) is a formal document that attests to Latanoprostene Bunod's compliance with Latanoprostene Bunod specifications and serves as a tool for batch-level quality control.
Latanoprostene Bunod CoA mostly includes findings from lab analyses of a specific batch. For each Latanoprostene Bunod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Latanoprostene Bunod may be tested according to a variety of international standards, such as European Pharmacopoeia (Latanoprostene Bunod EP), Latanoprostene Bunod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Latanoprostene Bunod USP).
LOOKING FOR A SUPPLIER?
